Shares of Eli Lilly were on the rise on Wednesday after Wall Street learned that the company is seeking FDA clearance for its COVID-19 antibody treatment. The company announced that it has submitted a request to the U.S. Food and Drug Administration for emergency authorization of the drug LY-CoV555. LY-CoV555 belongs to a class of … Continue reading “Eli Lilly Shares Soar After Company Requests FDA Clearance for Antibody Drug”
Biotech & Pharma
Bristol Myers to Acquire MyoKardia for $13 Billion
Wall Street learned this week that Bristol Myers is expanding its heart drug business with…
Illumina Says it Will Purchase Bezos-Backed Grail for $8B
Illumina, a global leader in genomics, announced this week that it will be acquiring the…
Gilead to Buy Cancer-drug Company Immunomedics for $21B
Over the weekend Gilead announced that it has agreed to purchase cancer-drug company Immunomedics for…
Trillium Therapeutics Shares Explode on Pfizer Investment
Shares of Trillium Therapeutics were skyrocketing over 40% on a $25 million Pfizer investment this…
Sarepta Therapeutics Shares Crumble After Regulators Request More Work to Be Done
Sarepta Therapeutics saw its share price dip on Thursday after regulators requested more work be…
AbbVie Inc. Signs $2.9 Billion Deal with China’s I-Mab
Drugmaker AbbVie Inc. has inked a deal with Chinese drug developer I-Mab to collaborate on…
AstraZeneca Pauses Late Stage COVID-19 Vaccine Trial
Wall Street learned on Tuesday that multinational pharmaceutical giant AstraZeneca has paused a late-stage trial…
Inovio Pharmaceuticals Falls on Short Seller’s Comments About Coronavirus Hype
Inovio Pharmaceuticals shares were falling on Wednesday after short seller Muddy Waters revealed that it…
Nestlé Health Science to Acquire Aimmune Therapeutics to Create Global Leader in Food Allergy Prevention
Biopharmaceutical giant Nestlé announced that it will be acquiring Aimmune Therapeutics to create a global…
Moderna Reveals its Coronavirus Vaccine Has had Promising Results
Biotech company Moderna has revealed this week that its coronavirus vaccine has shown promising results…
Abbott Laboratories Scores U.S. Authorization for a Rapid Covid-19 Antigen
On Wednesday medical devices and healthcare company Abbott Laboratories announced that it has won U.S.…
Novartis Investigational Immuno-oncology Drug Fails Skin Cancer Trial
Swiss drug maker Novartis announced over the weeknd that the company's investigational spartalizumab immuno-oncology drug…
Johnson & Johnson to Start Late-stage Coronavirus Vaccine Trial Next Month
Johnson & Johnson announced on Thursday that it would begin largest, late-stage trial testing a…